Skip to main content

Table 1 Outcomes of glove single-port laparoscopy-assisted transanal total mesorectal excision

From: Glove single-port laparoscopy-assisted transanal total mesorectal excision for low rectal cancer: a preliminary report

 

Patient#1

Patient#2

Patient#3

Patient#4

Patient#5

Mean ± SD

Age (years)

43

58

68

62

66

59.4 ± 9.94

Gender

Female

Male

Male

Female

Male

Body mass index (kg/m2)

19.5

23.5

23.2

25.2

24.6

23.2 ± 2.22

ASA score

1

1

2

2

1

Underlying disease

No

No

HBP

No

No

Previous abdominal operation

No

No

No

No

No

Distance from anal verge (cm)

5.0

6.0

4.0

5.0

4.0

4.8 ± 0.84

Diameter of tumor (cm)

1.5

3.0

2.0

2.5

2.0

2.2 ± 0.57

Tumor position

Left lateral

Anterior

Posterior

Anterior

Anterior

Neoadjuvant therapy

Yes

No

No

No

No

Operative time (min)

280

360

400

310

340

338.0 ± 46.04

Estimated blood loss (ml)

50

150

50

80

50

76.0 ± 43.46

Length of specimen (cm)

9.0

10.0

8.0

9.0

10.0

9.2 ± 0.84

Lymph nodes harvested

12

13

11

12

13

12.2 ± 0.84

(y)TNM stage

yT1N0M0

T3N1M0

T1N0M0

T2N0M0

T2N1M0

Circumferential margin

Negative

Negative

Negative

Negative

Negative

Bowel movement (days)

3

2

3

4

3

3.0 ± 0.71

LOS (days)

8

7

9

10

9

8.6 ± 1.14

Conversion

No

No

No

No

No

Reoperation

No

No

No

No

No

Complications

No

Stoma prolapse

No

No

No

30-day readmission

No

No

No

No

No

Follow-up (months)

17.0

16.0

14.0

15.0

12.0

14.8 ± 1.92

  1. ASA American Society of Anesthesiologists, HBP high blood pressure, (y) TNM stage for patients that received neoadjuvant chemoradiotherapy, LOS length of hospital stay